Mycophenolate mofetil in renal transplant recipients with cyclosporine- associated nephrotoxicity a preliminary report

Transplantation

Volumn 65, Issue 11, 1998, Pages 1504-1506

  Ducloux, Didier ^a   Fournier, Veronique ^a   Bresson Vautrin, Catherine ^a   Rebibou, Jean Michel ^a   Billerey, Claude ^a   Saint Hillier, Yves ^a   Chalopin, Jean Marc ^a  

^a HÔPITAL SAINT JACQUES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPETITIVE INHIBITION; CREATININE BLOOD LEVEL; DRUG EFFECT; FEMALE; FOLLOW UP; GLYCOSYLATION; GRAFT VERSUS HOST REACTION; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; RECIPIENT;

AGED; CREATININE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; LIPIDS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE CARE; RETREATMENT;

EID: 0032526102     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199806150-00019     Document Type: Article

References (10)

1. Meyers B, Ross J, Newton L, Luetscher J, Periroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699.
2. Almond PS, Gillingham KJ, Sibley R, et al. Renal transplant function after ten years of cyclosporine. Transplantation 1992; 53: 316.
3. Deray G, Benhmida M, Le Hoang P, et al. Renal function and blood pressure in patients receiving long-term, low-dose cyclosporine therapy for idiopathic autoimmune uveitis. Ann Int Med 1992; 117: 578.
4. Wrenshall LE, Matas AJ, Canafax DM, et al. An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone. Transplantation 1990; 50: 233.
5. Almond PS, Matas A, Gillingham KJ, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
6. Hall BM, Tiller DJ, Hardie I. Comparison of three immunosuppressive regimens in cadaver renal transplantation: long term cyclosporine, short term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. N Engl J Med 1988; 318: 1499.
7. Morris PJ, French ME, Dunnill MS, et al. A controlled trial of cyclosporine withdrawal in renal transplantation with conversion to azathioprine and prednisolone after three months. Transplantation 1983; 36: 273.
8. Halloran P, Tomlanovich MS, Hooftman CGL, et al. Mycophenolate mofetil in renal allograft recipients. Transplantation 1997; 63: 39.
9. Myers BD, Newton L, Boshkos C, et al. Chronic injury of human renal microvessels with low-dose cyclosporine therapy. Transplantation 1988; 46: 694.
10. Eich D, Thompson JA, Ko DJ, et al. Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary heart disease. J Heart Lung Transplant 1991; 10: 45.